GAO Report Supports Senate Compounding Bill

The report says FDA's authority to oversee drug compounding is "unclear," and two federal circuit court decisions resulted in differing authority in different parts of the country.

A new report from the Government Accountability Office (GAO) backs up congressional testimony by two top officials at the U.S. Food and Drug Administration about the challenges FDA inspectors face when trying to oversee the compounding pharmacy industry. The report, titled "Clear Authority and More Reliable Data Need to Strengthen FDA Oversight," points out that two federal circuit court decisions resulted in differing authority in different parts of the country.

The FDA officials -- Dr. Janet Woodcock, director of the Center for Drug Evaluation and Research at FDA, and Dr. Margaret Hamburg, commissioner of Food and Drugs, testified before U.S. House of Representatives committees in November 2012, April 2013, May 2013, and July 2013 as Congress considered possible legislative responses to the fungal meningitis outbreak associated with the New England Compounding Center. Both said their agency’s inspection authority is limited, and the GAO report agrees.

From 2002 through 2012, FDA officials had to obtain 11 warrants to gain access to drug compounders' facilities that had challenged its inspection authority, according to the report, which says GAO "also found that while FDA and national pharmacy organization officials generally agreed that states regulate the practice of pharmacy and FDA regulates drug manufacturing, there was no consensus on whether compounding drugs in large quantities--in anticipation of individual prescriptions or without prescriptions--and selling those drugs across state lines falls within the practice of pharmacy or is a type of drug manufacturing that should be overseen by FDA. This lack of consensus and differing FDA authority to oversee compounded drugs across the country has resulted in gaps in oversight of drug compounding."

The report supports the need for Congress to pass S. 959, The Pharmaceutical Quality, Security, and Accountability Act, which was introduced by the leaders of the U.S. Senate Health, Education, Labor and Pensions Committee: Chairman Tom Harkin, D-Iowa, and Ranking Member Lamar Alexander, R–Tenn., with support from other HELP members. The committee unanimously passed it in May, and HELP leaders are urging their colleagues to get it passed in the full Senate as soon as possible.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • The Top 5 Safety and Technology Trends to Watch in 2019

    Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

  • Get the Ultimate Guide to OSHA Recordkeeping

    OSHA’s Form 300A posting deadline is February 1! Are you prepared? To help answer your key recordkeeping questions, IndustrySafe put together this guide with critical compliance information.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe

OH&S Digital Edition

  • OHS Magazine Digital Edition - January 2019

    January 2019

    Featuring:

    • PREVENTING ERRORS
      Production vs. Safety 
    • EMERGENCY SHOWERS & EYEWASH
      Meeting the Requirements for Emergency Equipment
    • CONSTRUCTION SAFETY
      The State of Contractor Safety
    • FOOT PROTECTION
      The Three Keys to Effective Chemical Management
    View This Issue